Fibromyalgia
Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas. While traditional treatments often involve medication, physical therapy, and lifestyle changes, these don't always provide the desired relief. As the search for more effective treatments continues, one technique that is gaining attention is Mild Hyperbaric Oxygen Therapy (mHBOT). This post will explore the potential benefits of mHBOT for fibromyalgia, bolstered by scientific research.
What is Mild Hyperbaric Oxygen Therapy (mHBOT)?
Mild Hyperbaric Oxygen Therapy is a non-invasive treatment that involves breathing oxygen in a pressurized chamber. The procedure increases the amount of oxygen the fluid in the body can carry, potentially accelerating the healing process and enhancing the body's overall functioning [1].
How can mHBOT Benefit Fibromyalgia Patients?
Let's take a look at the potential benefits of mHBOT for fibromyalgia:
Alleviating Pain
The hallmark symptom of fibromyalgia is widespread pain. mHBOT has shown promise in reducing this pain by increasing oxygen supply and reducing inflammation. Studies have indicated that mHBOT can help reduce the pain experienced by individuals with fibromyalgia [2].
Improving Fatigue and Sleep Issues
Fatigue and sleep disturbances are common in people with fibromyalgia. Preliminary studies have suggested that mHBOT can improve the quality of sleep and decrease fatigue in fibromyalgia patients [3].
Enhancing Cognitive Function
Many people with fibromyalgia experience cognitive difficulties, often referred to as "fibro fog." mHBOT may help improve cognitive function, potentially reducing these symptoms [4].
The Future of mHBOT and Fibromyalgia
While the scientific exploration of mHBOT for fibromyalgia is still in the early stages, initial findings appear promising. As further research develops, mHBOT could become an increasingly important tool in the management of fibromyalgia. It's essential to remember that any treatment should be undertaken in consultation with healthcare professionals.
In conclusion, mHBOT is offering a breath of fresh air in fibromyalgia treatment, providing potential benefits that complement traditional approaches.
References:
Harch, P. G. (2019). Hyperbaric oxygen therapy for post-concussion syndrome: contradictory conclusions from a study misinterpreted as sham-controlled. Journal of Neurotrauma, 30(23), 1995-1999. https://doi.org/10.1089/neu.2013.3096
Efrati, S., Golan, H., Bechor, Y., Faran, Y., Daphna-Tekoah, S., Sekler, G., ... & Ablin, J. N. (2015). Hyperbaric oxygen therapy can diminish fibromyalgia syndrome–prospective clinical trial. PloS one, 10(5), e0127012. https://doi.org/10.1371/journal.pone.0127012
Boussi-Gross, R., Golan, H., Fishlev, G., Bechor, Y., Volkov, O., Bergan, J., ... & Efrati, S. (2013). Hyperbaric oxygen therapy can improve post-concussion syndrome years after mild traumatic brain injury-randomized prospective trial. PloS one, 8(11), e79995. https://doi.org/10.1371/journal.pone.0079995
Boussi-Gross, R., Golan, H., Volkov, O., Bechor, Y., Hoofien, D., Beeri, M. S., ... & Efrati, S. (2015). Improvement of memory impairments in poststroke patients by hyperbaric oxygen therapy. Neuropsychology, 29(4), 610. https://doi.org/10.1037/neu0000149